Food and Drug Administration, Lilly and weight loss
Compounding group sues FDA for removing Lilly's weight loss drug from shortage list
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s blockbuster weight loss and diabetes drugs from its shortage list last week,
Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit cheaper copycat versions.
Lilly weight-loss drug copycats dealt blow as shortage ends
Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., threatening to upend the many knockoffs that became popular when patients couldn’t find the brand-name medicines.
What end of Eli Lilly's weight-loss drug shortage means for the competition
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand.
Weight-Loss Drugs Are Everywhere Now. How the GLP-1 Copycats Took Over.
Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
The announcement is a blow to the compounding pharmacies that have made cheaper, off-brand versions of the medication The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over,
Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings
In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and weight loss not meeting patients' expectations.
Best Life on MSN1h
Biotech Exec Warns That Weight-Loss Drugs Do "More Harm Than Good"
T here's always a new headline about weight-loss drugs, whether it's sharing new data on how many pounds someone has lost or ...
2 Next-Gen Weight Loss Stocks That Are Worth Buying Right Now
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
A 4-Week Weight-Loss Workout Plan You'll Actually Stick With
A trainer outlines how to perform his four-week weight-loss workout program to build healthier habits through balanced, achievable workouts.
Psychology Today4h
Benefits of Weight Loss for Those With Severe Mental Illness
Many people suffering from severe mental illnesses are significantly overweight. New weight loss medications may help extend life expectancy.
Bunnie Xo Is 'Microdosing' Weight-Loss Medication, Says She's 'Hungry as S---'
Dumb Blonde” podcast host Bunnie XO said she’s already lost more than a pound — but said she's “microdosing” tirzepatide ...
What Is the Ideal Fat-Burning Heart Rate for Weight Loss?
A trainer shares valuable insights on the ideal fat-burning heart rate for weight loss from years of helping clients achieve ...
Science Daily5d
Diet and Weight Loss News
Sep. 23, 2024 — With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might ... Study of Former NFL Players ...
Hosted on MSN4h
Texas Grandma's 253-Lb Weight Loss Journey: How She Revived Her Thyroid-No Surgery, No Ozempic
If you want to slim down without weight-loss surgery or Ozempic, Traci Day might be your poster girl. When the Texas ...